Phase 3 study (TRIUMPH-4), condition: Obesity, Overweight, Osteo Arthritis Knee. The main purpose of this study is to evaluate the safety and efficacy of retatrutide once-weekly in participants who have obesity or are overweight and have osteoarthritis (OA) of the knee. The study will lasts about 77 weeks. Enrolment: 445 participants. Status: completed. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.
Checked 2026-08-08 · next review due 2026-11-08
← Back to the Record